Rentschler, CGT Catapult, and Refeyn Sign AAV Gene Therapy Agreement
Rentschler Biopharma agreed to collaborate with Cell and Gene Therapy Catapult and Refeyn to develop and apply novel process analytical technologies (PAT) to improve the...
Manufacturing Tech Can Help Make Gene Therapies More Accessible
Gene therapy firms face manufacturing and regulatory challenges that slow development and limit patient access. The good news is that new technologies have the potential...
Cell and Gene Therapy Scale-Up Challenges
Cell and gene therapy developers looking to move to commercial manufacture should embrace innovative systems, says new U.K.-based technology supplier Cellular Origins. Firms sometimes struggle...